Info for Patients
1. INFORMATION FOR THE PATIENT
Scenar technology – is it the future ? (Published in the International Travel Insurance Journal - R Cumbers April 2008)
Imagine there was a way to treat pain and acute health conditions quickly and effectively without complications and side effects, to be able to reverse many chronic diseases that are seen as irreversible by the mainstream orthodox medical fraternity. Now imagine that this treatment can be delivered by a hand held device no bigger than a TV remote control, weighs less than 300 grams, runs on three 1.5 volt batteries for months at a time, needs minimal training and can act as a heart defibrillator. If all this sounds too good to be true then you have never experienced Scenar technology close up.
Dubbed “the Star Trek device” by the European press, Scenar (an acronym for Self- controlled Energo Neuro Adaptive Reflex) made its appearance onto the western stage in the latter half of the 1990’s as perestroika helped to unravel the Soviet Union. A team of Russian doctors and scientists at Sochi University developed Scenar technology in the late 1970’s as massive funding went into the ‘space race’; portability, ease of use and effectiveness were of paramount importance.
How it works
Scenar technology is a fusion of knowledge that allows the device to mimic nerve impulses in a biofeedback dialogue with the central nervous system, a dynamic communication that facilitates internal balance and the re-establishment of homeostasis. A healthy coherent body has the ability to deal with pathology quickly by harnessing its own internal pharmacy of bioactive compounds, producing healing that the conscious mind is often unaware of or at worst is projected as a fast moving progression of symptoms resulting in a return to normality or good health. When repetitive pathological signals cannot be processed, the body eventually fails to recognise that it has a problem and effectively stops communicating with the pathology, creating an energy cyst – isolated from the body’s control.
The Scenar is operated by placing the electrode directly on the skin and can usually be sensed by the recipient as a pleasant tingling sensation. As the operator moves the device over the skin information is collected that identifies areas of ‘small asymmetry’ - pathology relating to tissues and organs connected via the ectodermic layer. Once located the Scenar becomes the Dr Dolittle of the cellular world, prompting and stimulating the nervous system to produce neuropeptides (nerve chemicals that are generally regarded as the most powerful of healing elements) in a response that is immediate and long lasting.
Why it works
As information is now flowing to previously unresponsive areas (energy cysts), communication continues long after the treatment is completed and helps other members of the body’s energetic orchestra bring about harmony and coherence. The success of Scenar therapy is effected by:
· Stimulation of all the skin structures. The skin develops from the same embryological layer as the nervous system allowing for treatment of internal organs via reflexive zones on the skins surface.
· Working along acupuncture meridians and neurological zones.
· Action on A, B and C nerve fibres creating powerful neuropeptide cascades.
· Restoring homeostasis and sympathetic / parasympathetic balance.
· Eliminating repetitive central nervous system patterns.
· Working directly on local spinal reflexes.
· Re-establishing normal membranous resonance.
· Through molecular polarization it normalizes adapted tissue polarities.
· By microphoresis as it stimulates selective re-absorption of trace elements and minerals from the skin.
The body can quickly adapt and become unresponsive to most electrical therapies, such as TENS, due to the consistent nature of the impulses This cannot happen with Scenar as every impulse is different to the previous one, the signals constantly changing as the electrical properties of the skin are analysed.
Names behind the science
The complex software that allowed this breakthrough to happen was developed by two exceptional electronic engineers, Ganadi Fursov and Alexander Nadtochy, who were both recognised at the highest level for their achievement.
The founding researcher behind the development of Scenar technology is Dr Alexander Karasev who demonstrated his invention to space program scientists while working at the Cosmonaut training centre in the 1970’s. Dr Karasev, who tends to shy away from publicity, said in his first ever interview with the BBC World service in 1999:
“If I had to prove it to you it would probably take me about 10 minutes. I can demonstrate it on anything, even the wrinkles on the skin. Rejuvenation. If you compare the treated and non-treated parts of the face, for instance, you can see the difference clearly. Or if you have a bruise somewhere it’ll take 10-15 minutes to demonstrate initial effect. I have introduced the SCENAR to maternity hospitals and it heals all the bruises and traumas in newly born babies within a few minutes”.
Alexander and his family have not used pharmaceutical drugs since it’s invention.
Two Doctors working with research teams greatly increased the effectiveness of the technology after perfecting powerful techniques that have led to the ‘almost unbelievable’ results achieved in Russian clinics and by an increasing number of medical staff and therapists worldwide. Like Dr Karasev, the brilliance of Dr Yori Gorfinkel and Professor Alexander Revenko has given the world a wonderful healing technology.
The Scenar is licensed in Europe for ‘pain relief’ and in the USA for ‘pain relief and muscle re-education’. Although its ability to quickly reduce pain is exceptional, we can see from statistics compiled from Russian clinics and Universities that ‘pain relief’ is almost a ‘side effect’ of something much more fundamental. Listed below is a summary of reports compiled by Scenar practitioners with varying degrees of experience, it should be noted that the average effectiveness includes complete recovery in 66% of cases:
· Musculoskeletal system - average 79%
· Circulatory system ** - average 82%
· Respiratory system - average 79%
· Digestive system - average 93%
· Male Genital, Urinary - average 89%
· Female Genital, Urinary, Obstetrics - average 78%
· Nervous system - average 81%
· Ear and mastoid process - average 82%
· Eye and Adnexa - average 93%
· Oral cavity, salivary glands and Jaws - average 91%
· Skin and subcutaneous tissue - average 68%
· Other applications - average 81%
** This includes 48 patients with acute heart failure, 47 recovered after one 25-minute treatment. Also 16 patients with sudden cardiac arrest, 12 recovered after one 10-minute treatment.
Scenar and emergency use – Pain Relief.
Scenar is used widely in Russia by para-medics and emergency Doctors. It is regarded as a ‘polyclinic’ and ‘ambulance in the pocket’. The dramatic effects on pain, oedema and traumatic injury are quite difficult to comprehend unless you have received such treatment or given it.
Professor Tarakanov, the clinical director of Rostov State Medical University compiled some results achieved by 43 emergency Doctors residing in 11 cities and towns. 610 patients received emergency treatment – 57% were given Scenar as a mono-therapy and 43% were given Scenar combined with drugs. The most frequent calls for emergency treatment were:
153 patients were suffering from neurovisceral hypertension stroke. Blood pressure was decreased on average between 15-20% and pulse rate by 10%. Pain (cardialgia and cephalgia) was virtually non-existent after 20-30 minutes treatment.
77 patients were divided into 3 groups suffering from osteochondrosis with radicular pain and neuralgia – pains in neck, head, chest and lower back. A 4-point scale was used to assess pain. On average pain reduced to 0.2 – 0.5 from 3 after 20 minutes of treatment.
33 patients with acute viral infection.
32 patients with dystonia.
26 patients with severe pain from angina pectoris.
24 patients with myofascial and muscular pain.
20 patients with contusions, fractures, haematomas.
16 patients with acute bronchial asthma.
9 patients with gastro duodenal disease.
9 patients with soft tissue bruising.
211 patients with other emergency issues.
A summary of the results shows that:
1.Scenar is an effective medical instrument for rendering immediate and on-going medical assistance
2.Scenar action relieves pain, recovers functionality, accelerates the clinical course of a pathological process and decreases its evidence
3The beneficial effect in the study is 87-92.3% irrespective of prior drug therapy.
4.Patients spend less time on drugs and subsequent rehabilitation
5.The number of medical errors is reduced
No unwanted side effects have been demonstrated in over 25 years of use in Russia and Europe. The only absolute contra-indication is for people with cardiac pacemakers; although certain other diseases and injuries should only be treated by practitioners with thorough training.
The technology has over 25 years proven research and hundreds of thousands of people have been successfully treated. The device can be used in confined spaces, is totally non-invasive, robust and portable, uses minimal energy, needs minimal training, reacts to the exact needs of the client at the time of treatment and is just as happy treating the knee of one patient and the heart of the next. Atlantic or Everest. Scenar works.
The efficiency of DENAS and Scenar therapy apparatus has been proven by many years' experience in use in Russia, adjacent states and other countries. As one would expect, the efficiency depends on the length of time the condition has been present, the operator's experience in using the therapeutic device, and the environment in which the patient resides.
If irreversible structural (morphologic) changes have taken place in organs affected by disease, no apparatuses or medicine exists to recover functions of these organs. Consequently in these cases influence from a DENAS device will not effect a full recovery, though improvement will usually take place when health is maintained with regular use of the apparatus.